EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metformin Use Is Associated With Better Cognitive Performance in Older Adults With Type 2 Diabetes: Exploratory Analysis of Vitamin B12 and Methylmalonic Acid Pathways in NHANES 2011–2014

Danial Fotros, Hanieh Sakhdari, Andrew C Shin iD

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11808-11820

DOI: 10.1111/dom.71396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 28.09.2026. Verfasst von Danial Fotros und 2 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiology of Nutrition Laboratory, Department of Nutritional Sciences, College of Health & Human Sciences, Texas Tech University, Lubbock, Texas, …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Methylmalonic Acid, Metformin, Vitamin B 12. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centers for Disease Control and Prevention, National Center for Health Statistics, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Metformin, the first‐line treatment for Type 2 diabetes mellitus (T2DM), may be neuroprotective but also lowers serum vitamin B12 by ~19%, raising concern that B12 depletion could offset this benefit. We used modern exploratory causal mediation methods in a nationally representative sample to test whether vitamin B12 and methylmalonic acid (MMA) mediate the metformin–cognition association. Materials and Methods We analysed NHANES 2011–2014 data from 587 adults aged ≥ 60 years with T2DM (408 metformin users, 179 users of other non‐insulin antidiabetics), using an active‐comparator design. The primary outcome was the Digit Symbol Substitution Test (DSST). Exploratory mediation analysis across four frameworks (bootstrap, parallel mediation, structural equation modeling, weighted quantile sum regression) tested whether B12 and MMA mediate the metformin–cognition association, supplemented by sensitivity, quantile regression, causal forest and Bayesian analyses.

Results

Metformin users had lower serum B12 (569.3 vs. 825.3 pg/mL; p = 0.026) but better cognitive performance (DSST 47.5 vs. 39.5; p < 0.001). Fully adjusted regression showed a 3.75‐point higher DSST score with metformin (95% CI −0.06 to 7.55; p = 0.053), significant under multiple imputation ( β = 3.49; p = 0.006). Across mediation frameworks, 95.1% of the effect was direct and B12/MMA‐independent. Benefit was concentrated in adults aged 60–69 years (interaction p = 0.003) and lower DSST quantiles.

Conclusions

Metformin is associated with better cognition in older T2DM adults. The association was not statistically explained by B12 or MMA. The benefit was concentrated in younger‐old and cognitively vulnerable subgroups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Methylmalonic AcidMetforminVitamin B 12CognitionHypoglycemic AgentsHumansFemaleAgedMaleMiddle AgedNutrition SurveysVitamin B 12 Deficiency

Stichwörter der Autor:innen

Digit Symbol Substitution Testcross‐sectional studymediation analysismethylmalonic acidpropensity score

Substanzen

Methylmalonic AcidMetforminVitamin B 12Hypoglycemic Agents

Autor:innen und Institutionen

  • Neurobiology of Nutrition Laboratory, Department of Nutritional Sciences, College of Health & Human Sciences, Texas Tech University, Lubbock, Texas, USA.
  • Department of Internal Medicine, Babol University of Medical Sciences, Babol, Iran.
  • Human Molecular Aging Center, Texas Tech University, Lubbock, Texas, USA.
  • Center of Excellence for Translational Neuroscience & Therapeutics, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
  • Center of Excellence for Integrated Health, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.

ORCID-Profile: Andrew C Shin

Förderung

  • Centers for Disease Control and Prevention, National Center for Health Statistics
  • Centers for Disease Control and Prevention

Zitieren

APA

Fotros, D., Sakhdari, H., & Shin, A. C. (2026). Metformin Use Is Associated With Better Cognitive Performance in Older Adults With Type 2 Diabetes: Exploratory Analysis of Vitamin B12 and Methylmalonic Acid Pathways in NHANES 2011–2014. Diabetes, Obesity and Metabolism, 28(12), 11808-11820. https://doi.org/10.1111/dom.71396

Vancouver

Fotros D, Sakhdari H, Shin AC. Metformin Use Is Associated With Better Cognitive Performance in Older Adults With Type 2 Diabetes: Exploratory Analysis of Vitamin B12 and Methylmalonic Acid Pathways in NHANES 2011–2014. Diabetes, Obesity and Metabolism. 2026;28(12):11808-11820. doi:10.1111/dom.71396

BibTeX
@article{Fotros2026,
  author = {Fotros, Danial and Sakhdari, Hanieh and Shin, Andrew C},
  title = {Metformin Use Is Associated With Better Cognitive Performance in Older Adults With Type 2 Diabetes: Exploratory Analysis of Vitamin B12 and Methylmalonic Acid Pathways in NHANES 2011–2014},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {12},
  pages = {11808--11820},
  doi = {10.1111/dom.71396}
}
Kostenlos starten →